Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 391,464 | 246,579 | 790,107 | 581,680 | 373,880 |
| Depreciation Amortization | 248,877 | 122,146 | 462,059 | 340,042 | 212,471 |
| Income taxes - deferred | -42,772 | -6,973 | -139,549 | -57,591 | -14,757 |
| Accounts receivable | -63,842 | -37,935 | -57,565 | -95,337 | -86,302 |
| Other Working Capital | -142,811 | -97,291 | 174,342 | 142,694 | -34,298 |
| Other Operating Activity | 138,385 | 74,224 | 333,051 | 243,712 | 192,013 |
| Operating Cash Flow | $529,301 | $300,750 | $1,562,445 | $1,155,200 | $643,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,991 | 29,991 | N/A | 30,080 | 61,253 |
| PPE Investments | -71,721 | -37,041 | -275,954 | -246,945 | -157,093 |
| Net Acquisitions | N/A | N/A | -25,000 | N/A | -25,000 |
| Purchase Of Investment | -1,904,617 | -1,142,327 | -3,184,197 | -1,818,316 | -1,071,770 |
| Sale Of Investment | 1,643,127 | 1,057,671 | 2,941,060 | 2,135,065 | 1,391,964 |
| Other Investing Activity | 0 | 0 | 178,218 | 0 | 0 |
| Investing Cash Flow | $-303,220 | $-91,706 | $-365,873 | $99,884 | $199,354 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -22,466 | -28,622 | -178,716 | -12,028 | -60,380 |
| Debt Issued | N/A | N/A | 986,980 | 986,980 | 986,980 |
| Debt Repayment | -10,867 | N/A | -1,512,474 | -1,512,474 | -1,512,474 |
| Common Stock Issued | 24,387 | 17,043 | 178,486 | 167,032 | 89,532 |
| Common Stock Repurchased | -57,631 | -57,631 | -738,938 | -559,767 | -559,767 |
| Other Financing Activity | 2,800 | 2,282 | 30,037 | 27,424 | 18,448 |
| Financing Cash Flow | $-63,777 | $-66,928 | $-1,234,625 | $-902,833 | $-1,037,661 |
| Exchange Rate Effect | 2,115 | -397 | 776 | -1,212 | 2,131 |
| Beginning Cash Position | 622,385 | 622,385 | 659,662 | 659,662 | 659,662 |
| End Cash Position | 786,804 | 764,104 | 622,385 | 1,010,701 | 466,493 |
| Net Cash Flow | $164,419 | $141,719 | $-37,277 | $351,039 | $-193,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | 529,301 | 300,750 | 1,562,445 | 1,155,200 | 643,007 |
| Capital Expenditure | -71,721 | -37,041 | -275,954 | -246,961 | -157,093 |
| Free Cash Flow | 457,580 | 263,709 | 1,286,491 | 908,239 | 485,914 |